Novo Nordisk AS (NVO)
110.14
-1.80
(-1.61%)
USD |
NYSE |
Nov 04, 13:04
Novo Nordisk Profit Margin (Quarterly): 29.46% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 29.46% |
| March 31, 2024 | 38.88% |
| December 31, 2023 | 33.35% |
| September 30, 2023 | 38.27% |
| June 30, 2023 | 35.78% |
| March 31, 2023 | 37.13% |
| December 31, 2022 | 28.26% |
| September 30, 2022 | 31.61% |
| June 30, 2022 | 32.27% |
| March 31, 2022 | 33.81% |
| December 31, 2021 | 28.41% |
| September 30, 2021 | 34.02% |
| June 30, 2021 | 36.69% |
| March 31, 2021 | 37.34% |
| December 31, 2020 | 28.99% |
| September 30, 2020 | 33.30% |
| June 30, 2020 | 35.41% |
| March 31, 2020 | 35.12% |
| December 31, 2019 | 26.89% |
| September 30, 2019 | 33.67% |
| June 30, 2019 | 31.94% |
| March 31, 2019 | 35.66% |
| December 31, 2018 | 28.58% |
| September 30, 2018 | 32.55% |
| June 30, 2018 | 37.74% |
| Date | Value |
|---|---|
| March 31, 2018 | 39.92% |
| December 31, 2017 | 29.48% |
| September 30, 2017 | 36.71% |
| June 30, 2017 | 34.75% |
| March 31, 2017 | 35.70% |
| December 31, 2016 | 29.42% |
| September 30, 2016 | 35.60% |
| June 30, 2016 | 36.30% |
| March 31, 2016 | 34.75% |
| December 31, 2015 | 28.60% |
| September 30, 2015 | 31.29% |
| June 30, 2015 | 30.83% |
| March 31, 2015 | 39.19% |
| December 31, 2014 | 26.56% |
| September 30, 2014 | 29.21% |
| June 30, 2014 | 32.34% |
| March 31, 2014 | 31.75% |
| December 31, 2013 | 27.90% |
| September 30, 2013 | 31.28% |
| June 30, 2013 | 31.50% |
| March 31, 2013 | 29.94% |
| December 31, 2012 | 27.45% |
| September 30, 2012 | 28.56% |
| June 30, 2012 | 27.46% |
| March 31, 2012 | 26.27% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
26.89%
Minimum
Dec 2019
38.88%
Maximum
Mar 2024
33.42%
Average
33.81%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
| Evaxion Biotech AS | -4.02K% |
| Amgen Inc | 33.28% |
| Viking Therapeutics Inc | -- |
| Adaptimmune Therapeutics PLC | 54.22% |
| Genfit SA | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 89.79% |
| Return on Assets | 28.81% |
| Return on Invested Capital | 68.37% |
| Gross Profit Margin (Quarterly) | 84.90% |
| Operating Margin (Quarterly) | 38.10% |
| Return on Net Operating Assets | 32.70% |